ÂÜÀòÂÒÂ×

Filip is a member of the Board of Directors of Confo Therapeutics, Virovet, and Remynd.

Filip is a Senior Investment Manager at Participatie Maatschappij Vlaanderen (PMV), with investment interests related to therapeutics and medical devices. Filip joined PMV from Vives, where he was an investment manager responsible for the life science franchise, and a member of the Board in Syndesi, Virovet and Aphea. He was further involved in – among others – Novadip, and the road towards IPO of iTeos Therapeutics (NASDAQ:ITOS). Prior to Vives, Filip held corporate positions in both small biotech as well as larger pharmaceutical companies.

Filip obtained a PhD in Pharmaceutical Sciences from Antwerp University (Belgium), a degree in Clinical Biology (Type A), Business Administration (IPO, Antwerp), and CEIPI certificate in Patent Law (U. Strassbourg, France).